Publications by authors named "Barbara Law"

Claim this Profile
T
Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in children.
Xavier Carbonell-Estrany, Eric A F Simões, Louis Bont, Paolo Manzoni, Heather J Zar, Barbara Law

Expert Rev Anti Infect Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the newly proposed Brighton Collaboration case definition for vaccine-induced immune thrombocytopenia and thrombosis.
Wan-Ting Huang, Barbara Law, Huyen Tran, Linda Schönborn, Wei-I Huang

Vaccine· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombosis with thrombocytopenia syndrome (TTS) and vaccine-induced immune thrombocytopenia and thrombosis (VITT): Brighton Collaboration case definitions and guidelines for data collection, analysis, and presentation of immunisation safety data.
Linda Schönborn, Sue Pavord, Vivien Mun Yee Chen, Menaka Pai, Dalha Haliru Gwarzo, Barbara Law

Vaccine· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anaphylaxis: Revision of the Brighton collaboration case definition.
Michael S Gold, Ananda Amarasinghe, Matthew Greenhawt, John M Kelso, Sonali Kochhar, Barbara Law

Vaccine· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anosmia: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
Yi-Chun Carol Liu, Flor M Munoz, Hector S Izurieta, Arina A Tamborska, Tom Solomon, Barbara J Law

Vaccine· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombosis and thromboembolism: Brighton collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
Jahnavi Gollamudi, Sarah E Sartain, Amir Hassan Navaei, Satinder Aneja, Pawandeep Kaur Dhawan, Barbara Law

Vaccine· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
Flor M Munoz, Jakob P Cramer, Cornelia L Dekker, Matthew Z Dudley, Barney S Graham, Barbara Law

Vaccine· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety.
Steven B Black, Barbara Law, Robert T Chen, Cornelia L Dekker, Miriam Sturkenboom

Vaccine· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
General determination of causation between Covid-19 vaccines and possible adverse events.
Lee M Hampton, Rakesh Aggarwal, Stephen J W Evans, Barbara Law

Vaccine· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quadrivalent human papillomavirus vaccination in girls and the risk of autoimmune disorders: the Ontario Grade 8 HPV Vaccine Cohort Study.
Erin Y Liu, Leah M Smith, Anne K Ellis, Heather Whitaker, Barbara Law

CMAJ· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canada's eight-component vaccine safety system: A primer for health care workers.
Noni E MacDonald, Barbara J Law

Paediatr Child Health· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canada's eight-component vaccine safety system: A primer for health care workers.
Noni E MacDonald, Barbara J Law

Paediatr Child Health· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guillain-BarrÉ Syndrome After Immunization in Canadian Children (1996-2012).
Karina A Top, Shalini Desai, Dorothy Moore, Barbara J Law, Wendy Vaudry

Pediatr Infect Dis J· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity, safety, and antibody persistence at 3, 5, and 10 years postvaccination in adolescents randomized to booster immunization with a combined tetanus, diphtheria, 5-component acellular pertussis, and inactivated poliomyelitis vaccine administered with a hepatitis B virus vaccine concurrently or 1 month apart.
Joanne Embree, Barbara Law, Tim Voloshen, Antigona Tomovici

Clin Vaccine Immunol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applicability of the Brighton Collaboration Case Definition for seizure after immunization in active and passive surveillance in Canada.
Karina A Top, Cora M Constantinescu, Julie Laflèche, Julie A Bettinger, David W Scheifele, Barbara J Law

Vaccine· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of causality of individual adverse events following immunization (AEFI): a WHO tool for global use.
Alberto E Tozzi, Edwin J Asturias, Madhava Ram Balakrishnan, Neal A Halsey, Barbara Law

Vaccine· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained elevation of systemic oxidative stress and inflammation in exacerbation and remission of asthma.
Judith C W Mak, Siu P Ho, Alice S S Ho, Barbara K W Law, Amy H K Cheung

ISRN Allergy· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of funded varicella immunization programs on varicella-related hospitalizations in IMPACT centers, Canada, 2000-2008.
Ben Tan, Julie Bettinger, Athena McConnell, David Scheifele, Scott Halperin, Barbara Law

Pediatr Infect Dis J· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On-time vaccination coverage in premature infants in Ontario, 2002-2009.
Kumanan Wilson, Steven Hawken, Kirsten Holdt Henningsen, Jeffery C Kwong, Shelley L Deeks, Barbara Law

Can J Public Health· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influenza vaccine effectiveness in the elderly based on administrative databases: change in immunization habit as a marker for bias.
Travis S Hottes, Danuta M Skowronski, Brett Hiebert, Naveed Z Janjua, Leslie L Roos, Barbara J Law

PLoS One· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The responses of Aboriginal Canadians to adjuvanted pandemic (H1N1) 2009 influenza vaccine.
Ethan Rubinstein, Gerald Predy, Laura Sauvé, Greg W Hammond, Fred Aoki, Barbara Law

CMAJ· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of adjuvanted pandemic H1N1(2009) influenza vaccine after one and two doses in young children.
David W Scheifele, Brian J Ward, Marc Dionne, Otto Vanderkooi, Joanne M Langley, Barbara Law

Pediatr Infect Dis J· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: probable transmission of vaccine strain of yellow fever virus to an infant via breast milk.
Susan Kuhn, Loreto Twele-Montecinos, Judy MacDonald, Patricia Webster, Barbara Law

CMAJ· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data.
James J Sejvar, Katrin S Kohl, Jane Gidudu, Anthony Amato, Nandini Bakshi, Barbara J Law

Vaccine· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study.
Michael S Gold, Jane Gidudu, Mich Erlewyn-Lajeunesse, Barbara Law,

Vaccine· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis